Patent Assignment
Reel/Frame 021935/0151
Assignment of Assignor's Interest
Recorded: 2008-12-08
Pages: 4
Assignor
UMANA, PABLO
Executed: 2008-09-17
Assignee
GLYCART BIOTECHNOLOGY AG
WAGISTRASSE 18, A SWISS COMPANY, SCHLIEREN, SWITZERLAND
Covered Property
(1)
Combination Therapy with Type I and Type Ii Anti-CD20 Antibodies
Application:
12/203,321 →
Publication:
US 2009/0060913
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 8, 2008
From: FRIESS, THOMAS; KLEIN, CHRISTIAN
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 021935/0300 →
Assignment of Assignor's Interest
Dec 8, 2008
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 021935/0427 →
Assignment of Assignor's Interest
May 27, 2010
From: HOFFMANN-LA ROCHE INC.
To: ROCHE GLYCART AG
Reel/Frame 024464/0418 →
Change of Name
Jun 29, 2010
From: GLYCART BIOTECHNOLOGY AG
To: ROCHE GLYCART AG
Reel/Frame 024624/0566 →